GSK3B and hepatocellular carcinoma: Jiang et al. [5] reported that PRMT9 was highly expressed in tumor tissues and promoted tumor cell migration and invasion by activating PI3K/Akt/GSK‐3β/Snail signaling in hepatocellular carcinoma.